Bradycardia News and Research

RSS
Bradycardia, ("heart slowness"), as applied to adult medicine, is defined as a resting heart rate of under 60 beats per minute, though it is seldom symptomatic until the rate drops below 50 beat/min.
Invasive surgeries could be avoided with new pacemakers powered by heartbeats

Invasive surgeries could be avoided with new pacemakers powered by heartbeats

Newly developed gene therapy helps decelerate aging process

Newly developed gene therapy helps decelerate aging process

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Researchers raise serious concerns about the accuracy of two baby monitors

Researchers raise serious concerns about the accuracy of two baby monitors

Aggressive lowering of blood pressure reduces MCI risk, study shows

Aggressive lowering of blood pressure reduces MCI risk, study shows

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

New leadless pacemakers carry reduced risks of complications and are less invasive

New leadless pacemakers carry reduced risks of complications and are less invasive

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

World’s smallest pacemaker for cardiology patients now offered at Medical City Dallas

World’s smallest pacemaker for cardiology patients now offered at Medical City Dallas

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Pacemakers and other cardiac devices reveal time, cause of death in some forensic cases

Pacemakers and other cardiac devices reveal time, cause of death in some forensic cases

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda announces accelerated approval from FDA for new lung cancer treatment

FDA approves first drug for treating rare form of Batten disease

FDA approves first drug for treating rare form of Batten disease

Pacing program can lead to seven-fold reduction in fainting episodes

Pacing program can lead to seven-fold reduction in fainting episodes

Scientists create organ-on-a-chip that can mimic heart's biomechanical properties

Scientists create organ-on-a-chip that can mimic heart's biomechanical properties

Houston Methodist offers world's smallest heart device for patients with bradycardia

Houston Methodist offers world's smallest heart device for patients with bradycardia